Showing results (181-190 of 989) with videos related to
Sort By:
Pageof 99
Therapeutic Advances in Respiratory Disease|March 12, 2025
Predicting response to benralizumab in patients with COPD: a plain language summary of publication of the GALATHEA and TERRANOVA studiesGerard J Criner, Dave Singh, Alberto Papi, et al.Therapeutic Advances in Respiratory Disease|March 12, 2025
A mixed-methods pilot study of domiciliary nasal high-flow therapy for breathlessness in people with chronic obstructive pulmonary disease who do not qualify for domiciliary long-term oxygen therapyNatasha Smallwood, Amy Pascoe, Catherine Buchan, et al.Therapeutic Advances in Respiratory Disease|March 12, 2025
Cohort multiple randomized controlled trial in pediatric asthma to assess the long- and short-term effects of eHealth interventions: protocol of the CIRCUS studyTamara Ruuls, Romi Sprengers, Vera Hengeveld, et al.Therapeutic Advances in Respiratory Disease|September 5, 2024
Outcomes of patients with blastomycosis-associated respiratory failure requiring veno-venous ECMO: a case seriesRoman Melamed, David M Tierney, Summer Martins, et al.Therapeutic Advances in Respiratory Disease|November 21, 2024
Patients' perspectives on the challenges associated with receiving non-oral pulmonary arterial hypertension treatment: a mixed methods studyAldo Aguirre-CamachoTherapeutic Advances in Respiratory Disease|November 8, 2024
Real-world therapeutic performance of pirfenidone for connective tissue disease-associated interstitial lung diseasesXueting Yuan, Chen Yu, Shengyun Liu, et al.Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.Therapeutic Advances in Respiratory Disease|August 12, 2024
Personalised indication of augmentation therapy for emphysema associated with severe alpha-1 antitrypsin deficiency: a case seriesCristina Aljama, Teresa Martin, Galo Granados, et al.Therapeutic Advances in Respiratory Disease|July 25, 2024
Extrafine single inhaler triple therapy effectiveness in COPD patients previously treated with multiple-inhaler triple therapy: the TRIWIN studyPaschalis Steiropoulos, Niki Georgatou, George Krommidas, et al.Therapeutic Advances in Respiratory Disease|August 30, 2023
Symptom versus exacerbation control: an evolution in GINA guidelines?Manuela Latorre, Riccardo Pistelli, Giovanna Elisiana Carpagnano, et al.Pageof 99